Clinical Trials
3 trialsNCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting
NCT04704934 2026-05-27
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)
Daiichi Sankyo
Phase 3 Active not recruiting
NCT04379596 2026-05-13
DG-03
AstraZeneca
Phase 2 Recruiting